Results 201 to 210 of about 1,421,119 (326)
Objective Our objective was to assess the incidence of major adverse cardiovascular events (MACEs) in patients with rheumatoid arthritis (RA) treated with JAK inhibitors (JAKi), tumor necrosis factor inhibitors (TNFi), or biologic disease‐modifying antirheumatic drugs with other modes of action (bDMARD‐OMA) in a multicountry, real‐world population ...
Romain Aymon+28 more
wiley +1 more source
Health Disparities in Rheumatology in the United States
Grace C Wright,1 Patrick M Zueger,2 Catherine Copley-Merriman,3 Shahnaz Khan,4 Jessica Costello,5 Alisha Krumbach,3 Priya Reddy,1,6 Oishi Tanjinatus,7 Alvin F Wells8 1Association of Women in Rheumatology, New York, NY, USA; 2Health Economics and Outcomes
Wright GC+8 more
doaj
Objective JAK inhibition (JAKi) is effective in seronegative spondyloarthropathy (SpA) spectrum disorders, but Tyk2 inhibition failed in SpA spectrum ulcerative colitis, and tofacitinib showed minimal benefit in Crohn disease, which highlights the complex role for JAK/STAT signaling in different inflammatory processes.
Sami Giryes+14 more
wiley +1 more source
Diagnostic heterogeneity and healthcare disparities: an underestimated source of bias in atrial fibrillation global burden estimates. [PDF]
Bisson A, Lenormand T, Fauchier L.
europepmc +1 more source
Applying Intersectionality to Better Characterize Healthcare Disparities for Critically Ill Adults. [PDF]
Day GL+3 more
europepmc +1 more source
Challenges and opportunities of AAM's (Ayushman Arogya Mandir) in mitigating healthcare disparities. [PDF]
Garg RK+7 more
europepmc +1 more source
NHAMCS has been a trusted source of data for healthcare disparities research since 1992. [PDF]
Schappert SM+4 more
europepmc +1 more source